BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28899690)

  • 1. Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis.
    Hulverson MA; Choi R; Arnold SLM; Schaefer DA; Hemphill A; McCloskey MC; Betzer DP; Müller J; Vidadala RSR; Whitman GR; Rivas KL; Barrett LK; Hackman RC; Love MS; McNamara CW; Shaughnessy TK; Kondratiuk A; Kurnick M; Banfor PN; Lynch JJ; Freiberg GM; Kempf DJ; Maly DJ; Riggs MW; Ojo KK; Van Voorhis WC
    Int J Parasitol; 2017 Oct; 47(12):753-763. PubMed ID: 28899690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.
    Schaefer DA; Betzer DP; Smith KD; Millman ZG; Michalski HC; Menchaca SE; Zambriski JA; Ojo KK; Hulverson MA; Arnold SL; Rivas KL; Vidadala RS; Huang W; Barrett LK; Maly DJ; Fan E; Van Voorhis WC; Riggs MW
    J Infect Dis; 2016 Dec; 214(12):1856-1864. PubMed ID: 27923949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
    Hulverson MA; Vinayak S; Choi R; Schaefer DA; Castellanos-Gonzalez A; Vidadala RSR; Brooks CF; Herbert GT; Betzer DP; Whitman GR; Sparks HN; Arnold SLM; Rivas KL; Barrett LK; White AC; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC; Ojo KK
    J Infect Dis; 2017 Apr; 215(8):1275-1284. PubMed ID: 28329187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
    Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
    J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection.
    Arnold SLM; Choi R; Hulverson MA; Schaefer DA; Vinayak S; Vidadala RSR; McCloskey MC; Whitman GR; Huang W; Barrett LK; Ojo KK; Fan E; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC
    J Infect Dis; 2017 Jul; 216(1):55-63. PubMed ID: 28541457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
    Huang W; Hulverson MA; Choi R; Arnold SLM; Zhang Z; McCloskey MC; Whitman GR; Hackman RC; Rivas KL; Barrett LK; Ojo KK; Van Voorhis WC; Fan E
    J Med Chem; 2019 Mar; 62(6):3135-3146. PubMed ID: 30830766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Schaefer DA; Betzer DP; McCloskey MC; Whitman GR; Huang W; Lee S; Pranata A; McLeod MD; Marsh KC; Kempf DJ; LeRoy BE; Zafiratos MT; Bielinski AL; Hackman RC; Ojo KK; Arnold SLM; Barrett LK; Tzipori S; Riggs MW; Fan E; Van Voorhis WC
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0142522. PubMed ID: 36920244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel CDPK1 inhibitor--a potential treatment for cryptosporidiosis in calves?
    Lendner M; Böttcher D; Delling C; Ojo KK; Van Voorhis WC; Daugschies A
    Parasitol Res; 2015 Jan; 114(1):335-6. PubMed ID: 25398685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
    Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Vidadala RSR; Whitman GR; Vidadala VN; Ojo KK; Barrett LK; Lynch JJ; Marsh K; Kempf DJ; Maly DJ; Van Voorhis WC
    ACS Infect Dis; 2021 May; 7(5):1200-1207. PubMed ID: 33565854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
    Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
    J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy.
    Ojo KK; Dangoudoubiyam S; Verma SK; Scheele S; DeRocher AE; Yeargan M; Choi R; Smith TR; Rivas KL; Hulverson MA; Barrett LK; Fan E; Maly DJ; Parsons M; Dubey JP; Howe DK; Van Voorhis WC
    Int J Parasitol; 2016 Dec; 46(13-14):871-880. PubMed ID: 27729271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis.
    Lee S; Ginese M; Beamer G; Danz HR; Girouard DJ; Chapman-Bonofiglio SP; Lee M; Hulverson MA; Choi R; Whitman GR; Ojo KK; Arnold SLM; Van Voorhis WC; Tzipori S
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned.
    Choi R; Hulverson MA; Huang W; Vidadala RSR; Whitman GR; Barrett LK; Schaefer DA; Betzer DP; Riggs MW; Doggett JS; Hemphill A; Ortega-Mora LM; McCloskey MC; Arnold SLM; Hackman RC; Marsh KC; Lynch JJ; Freiberg GM; Leroy BE; Kempf DJ; Choy RKM; de Hostos EL; Maly DJ; Fan E; Ojo KK; Van Voorhis WC
    Int J Parasitol; 2020 May; 50(5):413-422. PubMed ID: 32224121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.
    Manjunatha UH; Vinayak S; Zambriski JA; Chao AT; Sy T; Noble CG; Bonamy GMC; Kondreddi RR; Zou B; Gedeck P; Brooks CF; Herbert GT; Sateriale A; Tandel J; Noh S; Lakshminarayana SB; Lim SH; Goodman LB; Bodenreider C; Feng G; Zhang L; Blasco F; Wagner J; Leong FJ; Striepen B; Diagana TT
    Nature; 2017 Jun; 546(7658):376-380. PubMed ID: 28562588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
    Smith LM; Bonafonte MT; Campbell LD; Mead JR
    Exp Parasitol; 2001 Jul; 98(3):123-33. PubMed ID: 11527435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite Cryptosporidium.
    Arnold SLM; Choi R; Hulverson MA; Whitman GR; Mccloskey MC; Dorr CS; Vidadala RSR; Khatod M; Morada M; Barrett LK; Maly DJ; Yarlett N; Van Voorhis WC
    J Infect Dis; 2019 Aug; 220(7):1188-1198. PubMed ID: 31180118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of benzimidazoles against cryptosporidiosis in neonatal BALB/c mice.
    Fayer R; Fetterer R
    J Parasitol; 1995 Oct; 81(5):794-5. PubMed ID: 7472880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice.
    Barrier M; Lacroix-Lamandé S; Mancassola R; Auray G; Bernardet N; Chaussé AM; Uematsu S; Akira S; Laurent F
    J Infect Dis; 2006 May; 193(10):1400-7. PubMed ID: 16619188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.